SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-007082
Filing Date
2018-08-14
Accepted
2018-08-14 16:31:54
Documents
57
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q aptx-20180630x10q.htm 10-Q 1782651
2 EX-31.1 aptx-20180630ex3116965e9.htm EX-31.1 16008
3 EX-31.2 aptx-20180630ex312c8f786.htm EX-31.2 19622
4 EX-32.1 aptx-20180630ex3212ce292.htm EX-32.1 15297
  Complete submission text file 0001558370-18-007082.txt   4772784

Data Files

Seq Description Document Type Size
5 EX-101.INS aptx-20180630.xml EX-101.INS 812927
6 EX-101.SCH aptx-20180630.xsd EX-101.SCH 29694
7 EX-101.CAL aptx-20180630_cal.xml EX-101.CAL 31264
8 EX-101.DEF aptx-20180630_def.xml EX-101.DEF 119233
9 EX-101.LAB aptx-20180630_lab.xml EX-101.LAB 249653
10 EX-101.PRE aptx-20180630_pre.xml EX-101.PRE 217414
Mailing Address 909 DAVIS STREET SUITE 600 EVANSTON IL 60201
Business Address 1801 MAPLE AVENUE SUITE 4300 EVANSTON IL 60201 847-871-0377
Aptinyx Inc. (Filer) CIK: 0001674365 (see all company filings)

IRS No.: 474626057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38535 | Film No.: 181018126
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1